Statins Disappoint in COPD and ARDS — Physician’s First Watch

Medical News |
May 19, 2014

Statins Disappoint in COPD and ARDS

By Larry Husten

Two NHLBI studies have failed to find any benefit for statins in patients with chronic obstructive pulmonary disease and acute respiratory distress syndrome. Both trials were stopped early by their data and safety monitoring boards for futility. The results were presented at American Thoracic Society's meeting and published in the New England Journal of Medicine.

Although the trials were negative, they needed to be performed, write editorialists. "We needed to bridge the gap between information gleaned by deduction from observation ... and something gleaned from interventional experimentation... It would have been a big mistake to accept the findings without a test... Had we accepted the observational data at face value, we might have spent the cost of the trials many times over in useless treatments before recognizing our errors. That raises a hard question: With the advent of big data, which observational associations should we test in rigorous trials?"

Adapted from CardioExchange.

Reader Comments (1)

FRANK RAJAN Physician, Emergency Medicine, Changanacherry

The obsession with statins have gone to such an extent that it seems too obvious that some are trying to find newer uses since the obsessive use of statins in the "supposed" prevention and treatment" of IHD is fast fading. The cholesterol myth has shattered.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.